Pink Sheet | COVID-19 Vaccine Distribution Confusion Grows as Eligibility Widens

Fed workforce vaccine mandate; $3 billion investment in vaccine supply chain; Read the details in the Medical Products Supply Chain Week in Review.

President Biden signed a comprehensive pro-competition Executive Order with various aspects affecting medical product supply chains, such as importing prescription drugs from Canada and banning “pay for delay” between pharmaceutical manufacturers. Read the details in the Medical Products Supply Chain Week in Review. 

President Biden announced a new milestone of 300 million COVID-19 vaccine doses administered. In addition, the FDA issued a draft guidance to distinguish between “remanufacturing” and “servicing” of medical devices. Read the details in the COVID-19 Medical Products Supply Chain Week in Review.

President Biden revealed a new plan to share COVID-19 vaccines with other countries, and the CDC allowed vaccine waste for opportunities to vaccinate every eligible person who presents at a vaccination site; both actions reflect the government’s confidence in vaccine supply. Read the details in the COVID-19 Medical Products Supply Chain Week in Review.

The FDA authorized the Pfizer COVID-19 vaccine for adolescent use and updated its inspection guidance again. In addition, President Biden announced reaching the 250 million vaccine shot milestone. Read the details in the COVID-19 Medical Products Supply Chain Week in Review.